Display options
Share it on

Circulation. 2015 Aug 25;132(8):720-30. doi: 10.1161/CIRCULATIONAHA.114.014932.

Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.

Circulation

Krzysztof Wrobel, Susanna R Stevens, Robert H Jones, Craig H Selzman, Andre Lamy, Thomas M Beaver, Ljubomir T Djokovic, Nan Wang, Eric J Velazquez, George Sopko, Irving L Kron, J Michael DiMaio, Robert E Michler, Kerry L Lee, Michael Yii, Chua Yeow Leng, Marian Zembala, Jean L Rouleau, Richard C Daly, Hussein R Al-Khalidi

Affiliations

  1. From Allenort Hospital, Warsaw, Poland and John Paul II Hospital, Krakow, Poland (K.W.); Duke Clinical Research Institute, Durham, NC (S.R.S.); Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC (R.H.J., E.J.V., K.L.L., H.R.A.); University of Utah, Salt Lake City, UT (C.H.S.); Hamilton General Hospital/McMaster University, Hamilton, ON, Canada (A.L.); Shands Hospital at the University of Florida, Gainesville (T.M.B.); Dedinje Cardiovascular Institute, Belgrade, Serbia (L.T.D.); Loma Linda University Medical Center, CA (N.W.); National Institutes of Health/National Heart, Blood, and Lung Institute, Bethesda, MD (G.S.); University of Virginia, Charlottesville (I.L.K.); Baylor University Medical Center, Dallas, TX (J.M.D.); Montefiore Medical Center and Albert Einstein College of Medicine, New York (R.E.M.); St. Vincent's Hospital Melbourne and University of Melbourne, Australia (M.Y.); National Heart Centre Singapore (C.Y.L.); Silesian Center for Heart Diseases in Zabrze, Poland (M.Z.); Montreal Heart Institute, University de Montréal, Canada (J.L.R.); and Mayo Clinic, Rochester, MN (R.C.D.).
  2. From Allenort Hospital, Warsaw, Poland and John Paul II Hospital, Krakow, Poland (K.W.); Duke Clinical Research Institute, Durham, NC (S.R.S.); Duke University School of Medicine and Duke Clinical Research Institute, Durham, NC (R.H.J., E.J.V., K.L.L., H.R.A.); University of Utah, Salt Lake City, UT (C.H.S.); Hamilton General Hospital/McMaster University, Hamilton, ON, Canada (A.L.); Shands Hospital at the University of Florida, Gainesville (T.M.B.); Dedinje Cardiovascular Institute, Belgrade, Serbia (L.T.D.); Loma Linda University Medical Center, CA (N.W.); National Institutes of Health/National Heart, Blood, and Lung Institute, Bethesda, MD (G.S.); University of Virginia, Charlottesville (I.L.K.); Baylor University Medical Center, Dallas, TX (J.M.D.); Montefiore Medical Center and Albert Einstein College of Medicine, New York (R.E.M.); St. Vincent's Hospital Melbourne and University of Melbourne, Australia (M.Y.); National Heart Centre Singapore (C.Y.L.); Silesian Center for Heart Diseases in Zabrze, Poland (M.Z.); Montreal Heart Institute, University de Montréal, Canada (J.L.R.); and Mayo Clinic, Rochester, MN (R.C.D.). [email protected].

PMID: 26304663 PMCID: PMC4551105 DOI: 10.1161/CIRCULATIONAHA.114.014932

Abstract

BACKGROUND: Patients with severe left ventricular dysfunction, ischemic heart failure, and coronary artery disease suitable for coronary artery bypass grafting (CABG) are at higher risk for surgical morbidity and mortality. Paradoxically, those patients with the most severe coronary artery disease and ventricular dysfunction who derive the greatest clinical benefit from CABG are also at the greatest operative risk, which makes decision making regarding whether to proceed to surgery difficult in such patients. To better inform such decision making, we analyzed the Surgical Treatment for Ischemic Heart Failure (STICH) CABG population for detailed information on perioperative risk and outcomes.

METHODS AND RESULTS: In both STICH trials (hypotheses), 2136 patients with a left ventricular ejection fraction of ≤35% and coronary artery disease were allocated to medical therapy, CABG plus medical therapy, or CABG with surgical ventricular reconstruction. Relationships of baseline characteristics and operative conduct with morbidity and mortality at 30 days were evaluated. There were a total of 1460 patients randomized to and receiving surgery, and 346 (≈25%) of these high-risk patients developed a severe complication within 30 days. Worsening renal insufficiency, cardiac arrest with cardiopulmonary resuscitation, and ventricular arrhythmias were the most frequent complications and those most commonly associated with death. Mortality at 30 days was 5.1% and was generally preceded by a serious complication (65 of 74 deaths). Left ventricular size, renal dysfunction, advanced age, and atrial fibrillation/flutter were significant preoperative predictors of mortality within 30 days. Cardiopulmonary bypass time was the only independent surgical variable predictive of 30-day mortality.

CONCLUSIONS: CABG can be performed with relatively low 30-day mortality in patients with left ventricular dysfunction. Serious postoperative complications occurred in nearly 1 in 4 patients and were associated with mortality.

CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00023595.

© 2015 American Heart Association, Inc.

Keywords: coronary artery disease; heart failure; myocardial revascularization; surgery

References

  1. J Thorac Cardiovasc Surg. 2007 Jul;134(1):53-8 - PubMed
  2. J Thorac Cardiovasc Surg. 2013 Nov;146(5):1139-1145.e6 - PubMed
  3. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):638-44 - PubMed
  4. Eur J Cardiothorac Surg. 2002 Jul;22(1):101-5 - PubMed
  5. Circulation. 1987 Jul;76(1):44-51 - PubMed
  6. Ann Thorac Surg. 2007 Sep;84(3):808-16 - PubMed
  7. J Thorac Cardiovasc Surg. 2007 Dec;134(6):1540-7 - PubMed
  8. Heart Surg Forum. 2004 Jan 1;7(1):45-50 - PubMed
  9. J Am Coll Cardiol. 2010 Aug 3;56(6):490-8 - PubMed
  10. Eur J Cardiothorac Surg. 2006 Mar;29(3):348-53 - PubMed
  11. Circ Heart Fail. 2013 May;6(3):443-50 - PubMed
  12. Ann Thorac Surg. 2003 Jun;75(6):1856-64; discussion 1864-5 - PubMed
  13. Eur Heart J. 2009 Aug;30(15):1824-7 - PubMed
  14. Ann Thorac Surg. 2013 May;95(5):1532-8 - PubMed
  15. N Engl J Med. 2014 Dec 4;371(23):2178-88 - PubMed
  16. Ann Thorac Surg. 2013 Jan;95(1):46-52 - PubMed
  17. Med Care. 2005 Feb;43(2):122-31 - PubMed
  18. Anesth Analg. 2009 May;108(5):1394-417 - PubMed
  19. Circulation. 2005 Aug 30;112(9 Suppl):I344-50 - PubMed
  20. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2720-6.e1-2 - PubMed
  21. J Am Coll Cardiol. 2014 Aug 12;64(6):553-61 - PubMed
  22. N Engl J Med. 2009 Apr 23;360(17):1705-17 - PubMed
  23. Eur J Cardiothorac Surg. 1999 Jul;16(1):9-13 - PubMed
  24. N Engl J Med. 2011 Apr 28;364(17):1607-16 - PubMed
  25. Circulation. 2012 May 29;125(21):2639-48 - PubMed
  26. Circulation. 2014 Jun 17;129(24):2547-56 - PubMed
  27. Ann Thorac Surg. 2012 Feb;93(2):523-30 - PubMed
  28. Circulation. 2006 Jul 4;114(1 Suppl):I331-8 - PubMed
  29. N Engl J Med. 2014 Apr 10;370(15):1379-81 - PubMed

MeSH terms

Publication Types

Grant support